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Abstract. Nipple-sparing mastectomies (NSMs) are increas-
ingly used in the surgical treatment of patients with breast 
cancer and for prevention of breast cancer. The present study 
was performed to review the outcomes of patients undergoing 
NSMs at a single large university setting. A retrospective 
chart review was performed on all patients undergoing NSMs 
from 2008-2014. Charts were reviewed for demographic 
data and patient characteristics. Tumor and breast size, 
cancer recurrence and complications were also evaluated. 
Descriptive statistics were utilized to summarize the find-
ings. From 2008-2014, 110 patients underwent 197 NSMs. 
The mean patient age was 44.4 years (range, 20-77). The 
average body mass index was 24 (range, 18-47). Breast weight 
was available for 106 specimens, with a mean weight of 
475.5 g (range, 124.1-1,625.0 g). Seventy-three NSMs were 
performed for cancer and 124 were performed prophylacti-
cally. The mean tumor width was 1.38 cm (range, 0-6.0 cm), 
with an average nipple to tumor distance of 5.87 cm (range, 
2.93-10.0 cm). Three (4%) patients required removal of the 
nipple areolar complex (NAC) due to pathological extension 
of the tumor. A total of 34 (17.2%) complications occurred, 
including infections, hematomas and nipple necrosis, with 
9 requiring removal of the NAC and 13 requiring removal 
of the tissue expander or implant. Smokers had a 36.0% 
(9/25) complication rate, compared with 14.5% (25/172) of 
nonsmokers (P<0.05). During follow-up, one recurrence was 
noted, located on the chest wall. There were no recurrences 
in the NAC group. Therefore, NSMs may safely be performed 
without compromising oncologic outcomes or increasing 
complication rates in properly selected patients.
Introduction
For nearly a century the standard surgical approach to 
treating breast cancer was to perform a Halstead radical 
mastectomy removing the breast, axillary lymph nodes and 
pectoralis muscle. It was believed that the more tissue that was 
removed the better the survival for the patient. This theory 
was disproven and surgeons began performing less invasive 
surgery in the 1970s and 1980s (1,2). With the publication of 
National Surgical Adjuvant Breast and Bowel Project protocol 
B-06, breast conserving surgery was determined to have 
equivalent results in terms of survival and local recurrence 
with the addition of radiation therapy, when compared with 
mastectomy (3). If deemed to be an appropriate candidate, 
patients have the choice between breast conserving surgery 
or mastectomy. The rates of breast conserving surgery have 
remained stable over the last decade, however the rates of 
women opting for contralateral prophylactic mastectomy 
have steadily increased for various reasons (4). For patients 
undergoing mastectomies, rates of reconstruction vary and 
≤42% undergo this procedure (5). Traditionally, mastectomy 
with reconstruction for the treatment of breast cancer has been 
performed via a skin‑sparing approach, as first described by 
Toth and Lappert (6) in 1991. Nipple and skin-sparing mastec-
tomies, with preservation of the nipple-areola complex (NAC), 
have generally been performed for the treatment of benign 
disease and prophylactically in women at high risk for the 
development of breast cancer (7-9).
One of the concerns regarding the safety of nipple-sparing 
mastectomies (NSMs) in the treatment of breast cancer 
patients is the potential increased risk of breast cancer recur-
rence. The terminal duct lobular unit has been identified as 
the location for the development of all breast cancer, and a 
2008 study identified the presence of terminal duct lobular 
units in the nipples of 9% of patients (10,11). The rate of occult 
malignancy detected in the NAC in mastectomy specimens 
has varied widely with studies reporting an incidence of 
1-31% (12-16). Over the years, a number of prospective and 
retrospective studies have demonstrated a cancer recurrence 
rate in the NAC of up to 2%, with local recurrence rates 
ranging from 1-6% (17-19). A more recent meta-analysis 
comparing NSM to skin-sparing mastectomy (SSM) and/or 
modified radical mastectomy (MRM) identified no difference 
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in overall survival, disease free survival or local recurrence 
amongst the groups in properly selected patients with early 
stage breast cancer (20).
Overall complication rates for NSM have been reported to 
be as high as 60% in certain older studies, with more recent 
data suggesting complication rates of 16-22% (21-22). In a 
2003 study published by Gerber et al (19) the complication rate 
of NSM was compared with SSM and MRM and the overall 
complication rates were 20, 20, and 18% respectively. Similar 
findings have been reported in more recent retrospective 
studies comparing NSM with SSM (16,21). With comparable 
complication and recurrence rates to SSM, more surgeons are 
offering NSM to patients as a more cosmetically appealing 
alternative.
The current study was undertaken to evaluate the outcomes 
of patients undergoing NSMs at a single, large university 
hospital. Specifically, complication rates and tumor recurrence 
were studied.
Patients and methods
Patients. A prospectively maintained database of all surgical 
patients with breast cancer treated between September 2008 
and June 2014 was queried following approval from the 
Washington University Institutional Review Board. A retro-
spective chart review was then undertaken for all patients 
who had undergone an NSM performed by one of two breast 
surgical oncologists with reconstruction performed by one of 
two plastic surgeons. Charts were reviewed for patient demo-
graphics, including age, body mass index (BMI) and smoking 
status. In those patients who underwent NSMs due to cancer, 
tumor characteristics were also recorded, including tumor 
size and nipple to tumor distance as well as tumor recurrence. 
All patients were required to have a tumor to nipple distance 
of >2 cm to be eligible for nipple-sparing mastectomy at our 
institution. The incision utilized, as well as the type of recon-
struction undertaken were also evaluated. For all patients, 
any complications occurring within 30 days of surgery were 
documented, including any additional surgical procedures that 
were performed.
Statistical analysis. Statistical analysis was performed 
utilizing Fisher's exact test for categorical variables and 
student's unpaired t-test for continuous variables utilizing 
SPSS software version 22 (IBM SPSS, Armonk, NY, USA). 
P<0.05 was considered to indicate a statistically significant 
difference.
Results
Patient demographics. In the 6-year study period, 110 patients 
underwent 197 NSMs. Twenty-three (20.9%) patients had a 
unilateral NSM, while 87 (79.1%) went on to have bilateral 
NSMs. Of the 197 procedures performed, 124 (62.9%) were 
prophylactic and 73 (37.1%) were completed for cancer. Of the 
patients presenting with a breast cancer diagnosis, 25 (34.2%) 
had ductal carcinoma in situ (DCIS), 32 (43.8%) were TNM 
Stage I, 14 (19.2%) were TNM Stage II and 2 (2.8%) were TNM 
Stage III. Nine (8%) patients underwent neoadjuvant chemo-
therapy, 17 (15.5%) were treated with adjuvant chemotherapy 
and 3 (2.7%) underwent neoadjuvant and adjuvant chemo-
therapy. Two (1.8%) patients had undergone previous breast 
conserving therapy with radiation therapy. Ten (9%) patients 
underwent adjuvant chest wall radiation due to positive or 
close (<1 mm) margins or lymph node involvement on final 
pathology results.
The mean age of all patients undergoing surgery was 
44.4 years (range, 20-77). Overall, the patients in the current 
study were at a healthy weight with an average BMI of 24, with 
a BMI range of 18-47. Breast weight was only documented 
for 106 specimens, with a mean weight of 475.5 g (range, 
124.1-1,625.0 g). Thirteen (11.8%) of the patients studied were 
active smokers at the time of surgery.
Complications. The overall complication rate in this study was 
17.3% (34/197; Table I). There was no statistically significant 
difference in complication rates based on patient age, BMI or 
breast weight. However, those patients who had complications 
were more likely to be smokers (26.5%) compared to patients 
without any complications (8.6%; P<0.05). Four of the patients 
who were smokers developed bilateral complications of infec-
tion and nipple necrosis. Thirteen patients underwent removal 
of their implant or tissue expander due to a complication and 
this was more common in smokers (25.0%) than nonsmokers 
(4.6%; P<0.05).
There was no difference in the rate of complications, 
whether the operation was performed prophylactically or as 
part of breast cancer treatment (Table I). We considered a posi-
tive nipple margin to be a complication; therefore those patients 
with a closer tumor to nipple distance on final pathology had 
a significantly higher complication rate (Table I). Of the 
patients with complications, 5 (14.7%) had undergone either 
prior chest wall radiation or adjuvant radiation compared with 
only 7 (4.3%) patients without complications (P<0.05). The 
most common complications were skin flap or nipple necrosis 
(12/34) and infection (11/34) (Table II). Five occurrences of 
necrosis required NAC reconstruction, 3 instances were exten-
sive necrosis necessitating implant removal and an additional 
2 required surgical revision of the incision. Of the 11 infec-
tions occurring in the 30-day postoperative period, 9 required 
removal of the implant and 1 patient required surgical revision 
of their wound. Five hematomas occurred postoperatively 
with 3 requiring surgery for evacuation of the hematoma and 
1 necessitating implant removal. A single seroma occurred in 
the 30-day postoperative period, which was treated with needle 
aspiration. One patient developed flash pulmonary edema in 
the immediate postoperative period but had had bilateral NSMs 
and therefore was considered to have had two complications.
Surgical technique. Twenty-seven (13.7%) NSMs were 
completed via a circumareolar approach, 71 (36%) via a lateral 
breast incision and 99 (50.3%) utilizing an inframammary 
incision. There was no difference in overall complication rates 
among the three incision types utilized (Table I). However, 
when evaluating the 9 complications that resulted in loss of the 
NAC, there was a significant difference amongst the 3 incision 
types utilized (Table III). Seven of the 9 (77.8%) instances 
of NAC loss occurred following the use of a circumareolar 
incision compared to 1 (11.1%) loss each with the lateral and 
inframammary approaches (P<0.05). The removal of the 
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NAC that occurred after both a lateral and inframammary 
approach was due to DCIS behind the nipple, whereas only 
1 NAC was removed following a circumareolar incision 
due to a positive nipple margin. The type of reconstruction 
performed did not affect complication rates (Table I). Overall, 
106 (53.8%) patients underwent reconstruction with tissue 
expander placement and 91 (46.2%) received direct-to-implant 
based reconstruction. There was no difference in complica-
tion rate among patients receiving a tissue expander (16.9%) 
and direct implant (17.6%) (P>0.05). However, a significantly 
larger percentage of patients receiving a direct implant (10.9%) 
underwent implant removal due to a complication than those 
with placement of a tissue expander (2.8%; P<0.05).
Outcomes. In the first 3 years of the study, 44 NSMs were 
performed with 9 (20.5%) complications, compared with a 
complication rate of 16.3% (25/153) in the final 3 years of the 
study (P>0.05). The complication rate has steadily declined, 
with only 5/37 (13.5%) patients experiencing a complication 
occurring in the most recent six months of the study.
Table I. Comparison of demographics, tumor characteristics and surgical data of patients undergoing nipple-sparing mastectomies 
with and without subsequent complications.
 No complications (n=163) Complications (n=34) P-value
Patient age, years (range) 44.1 (25-77) 43.6 (20-72) NS
BMI (range) 25.2 (19.9-31.2) 23.7 (17.9-47.2) NS
Smoker (%) 14 (8.6) 9 (26.5) <0.01
Prophylactic surgery (%) 105 (64.4) 19 (55.8) NS
Stage (%)
  0 21 (12.9) 4 (11.8) NS
  I 26 (16) 6 (17.6) NS
  II 10 (6.1) 4 (11.8) NS
  III 1 (0.6) 1 (3) NS
Breast weight, g (range)a 458 (124-1625) 545 (170-836) NS
Tumor size, cm (range)b  1.5 (0-6) 1.0 (0-1.05) NS
Tumor to nipple distance, cm (range)c 5.87 (2.93-10.7) 5.23 (0-8.51) <0.05
Chest wall radiation 7 (4.3)  5 (14.7) <0.05
Incision utilized
  Circumareolar 19 (11.7) 8 (23.5) NS
  Lateral 62 (38.0) 9 (26.5) NS
  Inframammary 82 (50.3) 17 (50) NS
Reconstruction
  Tissue expander 18 (52.9) 88 (54) NS
  Direct to implant 16 (47.1) 75 (46) NS
aPatient data not available for 78 patients without complications and 13 patients with complications. bPatient data not available for 3 patients 
without complications and 1 patient with complications. cPatient data not available for 19 patients without complications and 7 patients with 
complications. P‑values calculated using Student's unpaired t‑test and Fisher's exact test. NS, non‑significant.
Table II. All complications (n=34) and additional surgical procedures performed to correct the associated complication.
Complication type Number of complications Additional procedures required (n)
Positive nipple margin   3 Removal of NAC (3)
Hematoma   5 Evacuation (3), implant removal (1)
Infection 11 Implant removal (9), wound revision (1)
Necrosis 12 NAC reconstruction (5), implant removal (3),
  revision of incision (2)
Seroma   1 Aspiration
Flash pulmonary edema   2 None
NAC, nipple areolar complex.
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Follow-up ranged between 3 months and 6 years, and 
only one (1.4%) patient in the cohort who underwent an NSM 
for cancer ultimately developed a recurrence. This occurred 
in a patient with a T1N0 tumor, 4.75 cm from the NAC who 
developed a chest wall recurrence. There were no instances of 
tumor recurrence within the NAC in the current study.
Discussion
The rate of local recurrence in numerous studies of patients 
undergoing an NSM varies, ranging from 0-25.7% (18,19,23,24). 
In the studies demonstrating rates of local recurrence >10%, 
cancer recurrence in the lymph nodes was included in the 
rate (19,24). Gerber et al (19) evaluated 246 patients with an 
indication for MRM who were treated with MRM, SSM or 
NSM with axillary lymph node dissection, identifying no 
differences in the rates of local recurrence amongst the three 
groups after a mean follow-up period of 101 months. More 
recent studies have demonstrated much lower local recurrence 
rates, similar to the present findings (16,24). An analysis of 
1,006 procedures from the Italian National database of NSM, 
the local regional recurrence rate was 2.9% with a recurrence 
rate in the NAC of 0.7% (25). In the present study, a single 
recurrence occurred, yielding a local recurrence rate of 1.4%. 
This was a chest wall recurrence in a patient with stage I (T1N0) 
cancer who did not require adjuvant chemotherapy or radiation 
following NSM. No patients presented with recurrence in the 
NAC during the time period studied.
In order to decrease the likelihood of cancer involvement 
of the NAC, numerous studies have recommended that the 
tumor to NAC distance on pre-operative imaging be no closer 
than 2 cm (23,26-28). Tumors found to be closer than 2 cm to 
the NAC are considered to be a relative contraindication to 
pursuing NSM. The lower local recurrence rate in the current 
study is likely due in large part to patient selection, as there 
was a requirement that all imaging demonstrate a distance 
>2 cm between the tumor and the NAC. A previous study by 
Tang et al (29) evaluated their group's experience with positive 
nipple margins and management, including excision of only 
the nipple with retention of the areola, and identified that at a 
36-month median follow-up, no recurrences occurred in the 
nipple/NAC. This may expand the indications for NSM in the 
future.
The complication rate in the present study was 17.3%, 
which is comparable with the reported literature (21,25,30,31). 
In the current study, those patients with a closer tumor to 
nipple distance had a higher complication rate. Any patient 
requiring excision of the nipple-areolar complex (NAC) 
for any reason was considered to have had a complication. 
Therefore a higher complication rate associated with a close 
tumor to nipple distance is attributed to the three patients who 
had excision of the NAC for a final positive nipple margin with 
involvement of DCIS. The closest tumor to nipple margin, 
without a positive margin or complication, in this study was 
found to be 2.93 cm.
Although the rate of overall complications was similar 
from 2008-2011 and 2012-2014, when examining the data 
for 2014, as experience with the operation has increased the 
complication rate has decreased to 13.5%. As this is becoming 
a more common option for patients, the present study antici-
pates a further decline in complications.
Smoking is established to increase complication rates in 
breast surgery (5,31-36). In a prospective study published by 
Matsen et al (33) examining skin flap necrosis rates following 
any mastectomy with reconstruction, 14% of patients had 
some level of skin flap necrosis (33). Using univariate analysis, 
smoking was revealed to be a significant factor in necrosis 
rates (32). Similarly, in a study published in 2014, 6% of 
patients undergoing NSM were found to be smokers, and had 
an odds ratio of 3.3 for any complications compared with 
non-smokers (31). This trend was also evident in the present 
study, with patients who were smokers at the time of NSM 
having significantly more complications than non‑smokers 
and requiring removal of their implants or tissue expanders 
due to these complications.
One of the most well-described complications to occur 
after an NSM is skin or nipple necrosis, which at times neces-
sitates removal of the NAC. In the majority of contemporary 
studies, the necrosis rate has been found to be between 0 and 
7% (21,22,25,31). In the current study the total necrosis rate 
was 6%, with 5 (2.5%) patients requiring removal and recon-
struction of the NAC due to the extent of necrosis.
When NSMs were first being performed at the Washington 
University School of Medicine, one of three incision types 
was utilized: Circumareolar (which encompassed a portion 
of the NAC border), lateral radial and inframammary. The 
circumareolar approach was replaced by the lateral radial or 
inframammary incisions, as there was significantly less loss of 
the NAC when the incision did not involve the NAC. This has 
been demonstrated by numerous other studies (28,34,37). In 
a 2014 retrospective review of 500 NSMs, patients with inci-
sions encompassing the NAC had a complication rate of 21.1% 
compared to 8.5% when the inframammary incision was 
used (31). A meta-analysis of 48 studies published between 
1970 and 2013 evaluated whether incision type led to an 
increase in nipple necrosis, and revealed that a circumareolar 
incision yielded a 17.81% necrosis rate, whereas while radial/
lateral and inframammary incisions had necrosis rates of 8.83 
and 9.09%, respectively (21). Due to the increased number of 
complications and rate of nipple loss with a circumareolar 
approach in both the literature and in the present study, this 
has been abandoned at Washington University School of 
Medicine and NSMs are now performed through a lateral or 
inframammary incision only.
Historically, patients who underwent implant-based recon-
struction following NSM had tissue expanders placed at the 
Table III. Comparison of the incision utilized and the rate of 
NAC loss.
Incision utilized Loss of NAC (n=9) P-value
Circumareolar, n (%) 7 (77.8) <0.05
Lateral, n (%) 1 (11.1)
Inframammary, n (%) 1 (11.1)
P-value calculated using Fisher's exact test. NAC, nipple areolar 
complex.
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time of mastectomy, however immediate reconstruction with 
a silicone or saline implant following NSM has become more 
widely accepted in recent years. In a 2010 prospective study 
of 214 consecutive NSMs with immediate silicone implant 
reconstruction, the overall complication rate was 16% with 6% 
requiring explantation of the prostheses due to the complica-
tion (22). In 2012 the present study began performing NSM 
with direct-to-implant reconstruction and in the study period 
identified no difference in complication rates when a permanent 
implant was placed at the time of mastectomy in lieu of a tissue 
expander; however, more patients with direct implant-based 
reconstruction required removal of their implants.
There are limitations to the present study, as it was a retro-
spective chart review and certain medical data was missing 
or incomplete. For example, breast weight was only recorded 
for 106 breast specimens and therefore the current study was 
unable to delineate whether larger breast size increases compli-
cation rates. Although this is a retrospective study, it provides 
additional data regarding the oncologic safety and low compli-
cation rate of NSMs. It is unlikely that a randomized controlled 
trial may be offered to patients comparing NSM to SSM and 
MRM, as patients who are candidates for a NSM would not 
want to be randomized to a less cosmetically pleasing surgery.
In conclusion, the present study adds to the growing 
literature demonstrating the oncologic safety of NSMs with 
a local recurrence rate of 1.4% in properly selected patients 
with tumor to nipple distance >2 cm. Additionally, the current 
study also demonstrated a low complication rate, including 
a low rate of nipple-areolar loss with a lateral or inframam-
mary incision. These results further demonstrate that NSMs 
are safe and do not comprise oncologic outcomes or increase 
complication rates.
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